Whilst it is known that tumour cells displaying an altered CD9 and CD151 expression pattern have a higher invasive capacity than other cells, little is known as to what alteration of these tetraspanins does to the function and proteomic composition of EVs and what impact the changes will have on key metastatic functions. Here, CD9 is linked to neoplasm.